Who owns INOZYME PHARMA INC?
- Ticker: INZY
- CUSIP Number: 45790w108
Tip: Access positions for across all investors
Analyze quarterly positions in Inozyme Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inozyme Pharma stock
Who bought or sold INOZYME PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Adage Capital Partners GP | 5.2M | $14M | -9% | Dec 2024 |
|
| Pivotal bioVenture Partners Investment Advisor | 4.5M | $13M | 0% | Dec 2024 |
|
| Sofinnova Ventures | 4.3M | $12M | 0% | Dec 2024 |
|
| Affinity Asset Advisors | 4.0M | $11M | 41% | Dec 2024 |
|
| Rock Springs Capital Management | 3.9M | $11M | 2% | Dec 2024 |
|
| BlackRock | 3.8M | $11M | 9% | Dec 2024 |
|
| Vanguard Group | 2.6M | $7.3M | 0% | Dec 2024 |
|
| NEA Management Company | 2.4M | $6.8M | 0% | Dec 2024 |
|
| Eventide Asset Management | 2.2M | $6.1M | -46% | Dec 2024 |
|
| Millennium Management | 1.9M | $5.2M | 8% | Dec 2024 |
|
| FMR | 1.8M | $5.1M | -26% | Dec 2024 |
|
| Samsara BioCapital | 1.6M | $4.3M | 0% | Dec 2024 |
|
| Saturn V Capital Management | 1.4M | $3.8M | 0% | Dec 2024 |
|
| Sphera Funds Management | 1.2M | $3.3M | 0% | Dec 2024 |
|
| Geode Capital Management | 1.2M | $3.3M | 1% | Dec 2024 |
|
| Blue Owl Capital Holdings | 1.1M | $3.0M | -4% | Dec 2024 |
|
| State Street Corporation | 1.0M | $2.8M | -4% | Dec 2024 |
|
| Woodline Partners | 1.0M | $2.8M | 0% | Dec 2024 |
|
| Knott David M Jr | 695k | $1.9M | 23% | Dec 2024 |
|
| Citadel Advisors | 625k | $1.7M | 958% | Dec 2024 |
|
| Dimensional Fund Advisors | 505k | $1.4M | 13% | Dec 2024 |
|
| Northern Trust | 451k | $1.2M | 3% | Dec 2024 |
|
| Renaissance Technologies | 421k | $1.2M | 156% | Dec 2024 |
|
| Goldman Sachs Group | 253k | $700k | -44% | Dec 2024 |
|
| Nuveen Asset Management | 250k | $693k | 23% | Dec 2024 |
|
| Walleye Trading Advisors | 238k | $658k | 100% | Dec 2024 |
|
| Overbrook Management Corp. | 219k | $608k | 0% | Dec 2024 |
|
| Pale Fire Capital SE | 219k | $605k | 16% | Dec 2024 |
|
| UBS O'Connor | 201k | $557k | -11% | Dec 2024 |
|
| Wellington Management Company | 200k | $555k | -23% | Dec 2024 |
|
| Standard Life Aberdeen | 171k | $472k | 100% | Dec 2024 |
|
| Bank of New York Mellon | 156k | $431k | 0% | Dec 2024 |
|
| Morgan Stanley | 148k | $409k | -7% | Dec 2024 |
|
| Charles Schwab Investment Management | 143k | $397k | 0% | Dec 2024 |
|
| Jacobs Levy Equity Management | 130k | $359k | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 129k | $357k | 345% | Dec 2024 |
|
| Bank of America Corporation | 104k | $289k | -14% | Dec 2024 |
|
| Barclays | 92k | $254k | 19% | Dec 2024 |
|
| Jump Financial | 89k | $247k | 100% | Dec 2024 |
|
| Cubist Systematic Strategies | 84k | $233k | 100% | Dec 2024 |
|
| American Century Companies | 79k | $220k | 12% | Dec 2024 |
|
| Two Sigma Advisers | 79k | $218k | 224% | Dec 2024 |
|
| Rhumbline Advisers | 77k | $214k | 1% | Dec 2024 |
|
| ADAR1 Capital Management | 76k | $211k | 100% | Dec 2024 |
|
| Bridgeway Capital Management | 76k | $211k | -3% | Dec 2024 |
|
| Raymond James Financial | 74k | $205k | 100% | Dec 2024 |
|
| Susquehanna Fundamental Investments | 63k | $174k | 100% | Dec 2024 |
|
| Susquehanna International | 61k | $169k | 100% | Dec 2024 |
|
| Shay Capital | 54k | $148k | 100% | Dec 2024 |
|
| Resources Investment Advisors | 51k | $141k | 155% | Dec 2024 |
|
| Citigroup | 40k | $112k | 7% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 40k | $111k | 29% | Dec 2024 |
|
| Algert Coldiron Investors | 39k | $108k | 100% | Dec 2024 |
|
| UBS Group | 36k | $100k | 40% | Dec 2024 |
|
| Alliancebernstein | 35k | $97k | 0% | Dec 2024 |
|
| Two Sigma Investments | 32k | $88k | 100% | Dec 2024 |
|
| XTX Topco | 32k | $88k | 100% | Dec 2024 |
|
| Wells Fargo & Company | 32k | $88k | 29% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 30k | $82k | 5% | Dec 2024 |
|
| Corebridge Financial | 26k | $72k | 100% | Dec 2024 |
|
| Intech Investment Management | 25k | $68k | 100% | Dec 2024 |
|
| MetLife Investment Advisors | 24k | $66k | -14% | Dec 2024 |
|
| Palumbo Wealth Management | 23k | $65k | 52% | Dec 2024 |
|
| Manufacturers Life Insurance Company | 21k | $58k | 0% | Dec 2024 |
|
| Invesco | 20k | $55k | 29% | Dec 2024 |
|
| T. Rowe Price Associates | 20k | $55k | 18% | Dec 2024 |
|
| Readystate Asset Management | 19k | $53k | 0% | Dec 2024 |
|
| D. E. Shaw & Co | 18k | $49k | 100% | Dec 2024 |
|
| ProShare Advisors | 18k | $49k | 100% | Dec 2024 |
|
| Ing Investment Management | 17k | $48k | -8% | Dec 2024 |
|
| Parallel Advisors | 17k | $46k | 0% | Dec 2024 |
|
| SG Americas Securities | 16k | $44k | 3% | Dec 2024 |
|
| China Universal Asset Management | 14k | $38k | 100% | Dec 2024 |
|
| New York State Common Retirement Fund | 13k | $37k | 0% | Dec 2024 |
|
| Florida State Board of Administration | 12k | $34k | 0% | Dec 2024 |
|
| Graham Capital Management | 12k | $33k | 100% | Dec 2024 |
|
| Harvest Investment Services | 11k | $31k | 100% | Dec 2024 |
|
| Royal Bank of Canada | 8.6k | $22k | 55% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 6.7k | $19k | 100% | Dec 2024 |
|
| Federated Investors | 5.1k | $14k | 100% | Dec 2024 |
|
| Legal & General Group | 4.8k | $13k | 0% | Dec 2024 |
|
| Summit Investment Advisors | 4.8k | $13k | 0% | Dec 2024 |
|
| California State Teachers Retirement System | 3.7k | $10k | 0% | Dec 2024 |
|
| Tower Research Capital | 3.7k | $10k | 107% | Dec 2024 |
|
| Russell Investments | 3.5k | $9.6k | 100% | Dec 2024 |
|
| Mirae Asset Global Investments | 2.1k | $6.3k | 100% | Dec 2024 |
|
| Sterling Capital Management | 1.8k | $4.9k | 971% | Dec 2024 |
|
| Amalgamated Bank | 1.7k | $5.0k | 0% | Dec 2024 |
|
| Gf Fund Management | 1.3k | $3.7k | 100% | Dec 2024 |
|
| Smartleaf Asset Management | 730.00 | $2.1k | 100% | Dec 2024 |
|
| Simplex Trading | 327.00 | $0 | -64% | Dec 2024 |
|
| Skopos Labs | 314.00 | $869.999800 | 100% | Dec 2024 |
|
| Group One Trading | 215.00 | $596.001500 | -28% | Dec 2024 |
|
| CWM | 108.00 | $0 | 130% | Dec 2024 |
|
| Sachetta | 100.00 | $277.000000 | 0% | Dec 2024 |
|
| Rothschild Investment | 45.00 | $125.001000 | 100% | Dec 2024 |
|
| Pnc Financial Services | 35.00 | $96.999000 | 0% | Dec 2024 |
|
| SBI Securities | 34.00 | $93.999800 | 100% | Dec 2024 |
|
| EverSource Wealth Advisors | 5.00 | $14.000000 | 100% | Dec 2024 |
|
| IFP Advisors | 1.00 | $3.000000 | 100% | Dec 2024 |
|
Who sold out of Inozyme Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Samlyn Capital | Sep 2024 | 3.3M | $17M |
| Jane Street | Sep 2024 | 50k | $259k |
| ExodusPoint Capital Management | Sep 2024 | 48k | $251k |
| ALPS Advisors | Sep 2024 | 45k | $233k |
| GSA Capital Partners | Sep 2024 | 35k | $185k |
| Squarepoint Ops | Sep 2024 | 28k | $147k |
| Bailard | Sep 2024 | 24k | $127k |
| Fox Run Management | Sep 2024 | 15k | $80k |
| Meeder Asset Management | Sep 2024 | 15k | $80k |
| Values First Advisors | Sep 2024 | 15k | $77k |
| Virtu Financial | Sep 2024 | 12k | $64k |
| BFSG | Sep 2024 | 500.00 | $2.6k |
| SRS Capital Advisors | Sep 2024 | 475.00 | $2.5k |
| NISA Investment Advisors | Sep 2024 | 179.00 | $936.008900 |
| Allspring Global Investments Holdings | Sep 2024 | 66.00 | $345.001800 |
| Advisor Group Holdings | Sep 2024 | 50.00 | $262.000000 |
| Us Bancorp | Sep 2024 | 44.00 | $230.001200 |
| Capital Performance Advisors | Sep 2024 | 35.00 | $183.001000 |
| GAMMA Investing | Sep 2024 | 27.00 | $140.999400 |